The American Liver Foundation estimates that over 30% of the U.S. population has some degree of nonalcoholic fatty liver disease (NAFLD), the most common type of liver disease in the Western world.
Last month, one furloughed government worker made national headlines by saying she had to ration her insulin because she couldn’t afford her co-pay, nor the ER bill, during the government shutdown.
In an effort to help address adolescent drug abuse and misuse in Pennsylvania, The Rite Aid Foundation is bringing the Prescription Drug Safety program, an innovative digital course about prescription drug abuse prevention, to Harrisburg-area high schools.
Diplomat Pharmacy announced Friday that the company’s board of directors has appointed Dan Davison as chief financial officer and treasurer effective April 8, succeeding Atul Kavthekar.
The National Association of Chain Drug Stores Friday welcomed Senate legislation that would limit to a seven-day supply the initial prescriptions of opioids for acute pain — a move that is consistent with Centers for Disease Control and Prevention’s (CDC) guidelines. Sens. Kirsten Gillibrand (D.
The National Association of Chain Drug Stores (NACDS) praises the enactment of an electronic prescribing bill (SB 174), for controlled substance prescriptions for Schedule II through Schedule VI, which will help prevent opioid abuse. Arkansas Gov.
PARAMUS, N.J. – Glenmark Pharmaceuticals has received the Food and Drug Administration’s approval for generic BenzaClin (clindamycin and benzoyl peroxide gel, 1%/5%). The product, which is an acne treatment, is a generic of Valeant Bermuda’s branded product.
When the West Virginia Medicaid agency started managing the Medicaid managed care prescription drug benefit directly in July 2017, state officials were relying on an actuarial study forecasting a $30 million savings for the state.
A new National Institutes of Health (NIH)-funded study is underway that’s examining the effectiveness of putting pharmacists in the role of caring of people with substance use disorder.
Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and Drug Administration next month. Health and Human Services Secretary Alex Azar said Tuesday that Sharpless will take the reins of the FDA after the resignation of Scott Gottlieb.
The Healthcare Distribution Alliance recognized AbbVie US; AmerisourceBergen Corporation; Genentech, a Member of the Roche Group; McKesson Corporation and Pfizer, Inc., with the 2019 Distribution Management Award (DMA) for the MediLedger Project, a blockchain-enabled traceability initiative.
OXNARD, Calif. – CURE Pharmaceutical Tuesday announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD).
Lupin announced that it has received approval for its atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer’s Lipitor Tablets, 10 mg, 20 mg, 40 mg and 80 mg.
ARLINGTON, Va. – Morning Consult Friday published an opinion piece by the National Association of Chain Drug Stores (NACDS) entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.
In its ongoing effort to help combat the nation’s opioid epidemic across the country, CVS Health announced Friday the Aetna Foundation’s $1 million grant to the Northern Shenandoah Valley Substance Abuse Coalition (the Coalition), which will help fuel the Coalition’s new Law Enforcement Overdose Int
